Dose-dependent presystemic elimination of propranolol due to hepatic first-pass metabolism in rats.
Gastrointestinal first-pass elimination of propranolol and the effect of dose (1.0, 2.5, 5.0 and 10.0 mg kg-1) on its systemic availability were studied in male Wistar rats which received the drug intravenously, orally or intraportally. The plasma elimination half-life was not altered either by the route of administration or the dose. There was no gastrointestinal first-pass metabolism of propranolol, since the same systemic availability was obtained after oral and intraportal administration. Hepatic clearance was estimated to be constant at any dose. In contrast, the hepatic intrinsic clearance was found to be largely dependent on the portal dose.
Iwamoto
K
K
Watanabe
J
J
D000818:Animals; D001682:Biological Availability; D006207:Half-Life; D008099:Liver / Q000378:metabolism*; D008297:Male; D011433:Propranolol / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D011433:Propranolol